HomeAI

Category : AI

BioCity will present the late-breaking clinical trial data of its ETA selective antagonist SC0062 at the American Society of Nephrology (ASN) 2024 with simultaneous publication of the trial data in the Journal of the American Society of Nephrology (JASN)

SHANGHAI,Oct. 14,2024--BioCity Biopharma announced that a late-breaking clinical trial abstract of its endothelin receptor type A (ETA) selective antagonist SC0062 has been selected for oral presentat

AIOct 15, 2024

Wolf Winner Casino Launches Exciting New Tournament Feature for Slot Enthusiasts

Wolf Winner Casino Enhances Player Experience with the Introduction of Thrilling Slot Tournaments,Offering Opportunities for Big Wins

AIOct 15, 2024

MALAYSIAN INTERNATIONAL FURNITURE FAIR SET FOR BUMPER LAUNCH OF 2025 ASIA BUYING SEASON

Visitor Registration Opens KUALA LUMPUR,Malaysia,Oct. 14,2024-- The most global furniture B2B event in Southeast Asia,Malaysia International Furniture Fair (MIFF) – is on track for a huge opening to

AIOct 15, 2024

Positive guidance from the U.S. FDA on 64Cu-SAR-bisPSMA Phase III trial in patients with recurrence of prostate cancer

Highlights United States Food and Drug Administration (U.S. FDA) provided positive feedback on a pivotal Phase III trial for 64Cu-SAR-bisPSMA diagnostic in prostate cancer patients with biochemical r

AIOct 15, 2024

woobaby Dazzles with Spectacular Showcase at Shanghai Fashion Week

SHANGHAI,Oct. 14,2024--On October 11,2024,woobaby,China\'s up-and-coming designer children\'s clothing brand,premiered its autumn/winter collection at the KIDS WEAR showcase during Shanghai Fashion We

AIOct 15, 2024
1 ... 53 54 55 56 57 58 59 ... 131
Your premier source for cutting-edge news in the realms of technology, artificial intelligence, energy, and more. Explore the future of tech with Arinstar! Stay informed, stay inspired!

Quick Search

Explore our curated content, stay informed about groundbreaking innovations, and journey into the future of science and tech.

© ArinstarTechnology

Privacy Policy